- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05827445
Cutaneous Sensory Block Area of the Laparoscopic Assisted Transversus Abdominis Plane Block
Cutaneous Sensory Block Area of the Laparoscopic Assisted Transversus Abdominis Plane
The goal of this observational study is to assess the size and location of cutaneous sensory block area after dual laparoscopic assisted transverse abdominis plane block (L-TAP) with ropivacaine in patients undergoing laparoscopic cholecystectomy.
L-TAP is applied as a medial subcostal infiltration between midclavicular and central sternal lines and a lateral subcostal infiltration between midclavicular and anterior axillary line bilaterally.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Hillerød, Denmark, 3400
- Copenhagen University Hospital - North Zealand
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- undergoing elective laparoscopic cholecystectomy in a day surgery setting
- able to give oral and written consent
Exclusion Criteria:
- prior surgery to the upper abdominal wall
- known sensory deficits of the abdominal wall or thorax
- allergy to local anesthetics
- pregnancy
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cutaneous Sensory Block Area (CSBA)
Time Frame: 1.5 hours postoperatively
|
Assessment of the CSBA was done within the duration of the cutaneous sensory effect of the laparoscopic transverse abdominis plane block.
A gauze dipped in alcohol was tapped on the skin of the abdominal wall from the midsagittal line using a star-shaped approach with its center at the umbilicus to indicate cutaneous sensory changes in cold perception.
Changes were marked on the skin, confirmed twice, and a connecting line drawn to determine the CSBA.
The was size of the CSBA was calculated, and the location (supraumbilical or infraumbilical and medially or laterally to a vertical line through the anterior superior iliac spine.
|
1.5 hours postoperatively
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CSBA-LTAP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cholecystolithiasis
-
University of Roma La SapienzaCompleted
-
Hadassah Medical OrganizationCompleted
-
University of Roma La SapienzaCompleted
-
St John of God Hospital, ViennaCompleted
-
University of ZurichCompletedCholecystolithiasisSwitzerland
-
Hvidovre University HospitalUnknown
-
Centre Hospitalier Universitaire de BesanconNot yet recruiting
-
National Yang Ming Chiao Tung University HospitalCompleted
-
American University of Beirut Medical CenterMakassed General HospitalUnknown
-
Colchester Hospital University NHS Foundation TrustEthicon, Inc.Withdrawn